ArticleScientific reports2025
Plasma and MRI biomarkers capture neuronal damage in former professional boxers.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuroprotective therapy after traumatic brain injury: does the window for treatment extend for months?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026Article
- Genetic and environmental contributions to variation in plasma phosphorylated tau 217.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Repetitive Head Impacts (RHI) in boxing may increase the risk for neuronal damage. We evaluated blood-based biomarkers for neurodegeneration and Alzheimer's Disease (AD) pathology, clinical features, and MRI biomarkers in former professional boxers compared to patients with AD or patients with subjective cognitive decline (SCD). Nine former boxers were compared to age-matched patients (without single TBI or RHI) with biomarker confirmed AD (N = 15) or SCD (N = 14). Plasma samples were analyzed for amyloid beta (Aβ)42, Aβ42/40 ratio, phosphorylated tau (p-tau)181, p-tau217, glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) concentrations. Brain MRI images were processed through Freesurfer to compute disease-related regions-of-interest (ROIs) for AD, frontotemporal dementia (FTD), or chronic traumatic encephalopathy (CTE). Cognitive performance was assessed in memory and executive functioning (EF) domains. Five boxers had follow-up measurements after ~ 7 years. Former boxers had higher plasma GFAP, p-tau181 and p-tau217 than patients with SCD, lower volumes in all pre-specified disease-related brain regions. No differences on neuropsychological test scores between boxers and those with SCD were observed. Longitudinal analysis in the boxer group demonstrated elevation of plasma NfL and p-tau181 over time. The current study suggests the presence of biological processes indicative for neurodegeneration in former boxers, without evident clinical decline. Plasma GFAP, p-tau181 and p-tau217 may be promising biomarkers for indicating risk for neuronal damage following RHI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.